Tuesday, May 7, 2024 | 108,072 members | 37,113 rebates | Rebate Success Ratio: 98.4%
HomeMy RebatesRebates News / BlogRebates Information Library
Login
USERNAME:

PASSWORD:



Forgot password?   Register

Rebate-Tracker.com Information Library

Page History


I'm interested in this position http://teazr.me/02/indoor-garden-strawberry/ forzest von ranbaxy The mid-stage trial found Burlington, Massachusetts-basedCoronado’s drug TSO, or trichuris suis ova, failed to improvepatient response or send Crohn’s into remission any better thanplacebo, the company said in a statement today. TSO was safe andwell tolerated and patients taking the drug and the placeboreported abdominal pain as the most-common adverse event. Thetrial evaluated 125 patients on TSO and 125 who took a placebo.
Note: Not editing latest source